303 related articles for article (PubMed ID: 19750004)
61. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
[TBL] [Abstract][Full Text] [Related]
62. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
[TBL] [Abstract][Full Text] [Related]
63. ANGPTL3 gene variants in subjects with familial combined hyperlipidemia.
Bea AM; Franco-Marín E; Marco-Benedí V; Jarauta E; Gracia-Rubio I; Cenarro A; Civeira F; Lamiquiz-Moneo I
Sci Rep; 2021 Mar; 11(1):7002. PubMed ID: 33772079
[TBL] [Abstract][Full Text] [Related]
64. Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes.
Liu ML; Ylitalo K; Vakkilainen J; Nuotio I; Valkonen M; Lahdenperä S; Viikari J; Taskinen MR
Ann Med; 2002; 34(1):48-54. PubMed ID: 12014434
[TBL] [Abstract][Full Text] [Related]
65. Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia.
Meex SJ; van der Kallen CJ; van Greevenbroek MM; Eurlings PM; El Hasnaoui M; Evelo CT; Lindsey PJ; Luiken JJ; Glatz JF; de Bruin TW
FASEB J; 2005 Dec; 19(14):2063-5. PubMed ID: 16219805
[TBL] [Abstract][Full Text] [Related]
66. FABP4 plasma levels are increased in familial combined hyperlipidemia.
Cabré A; Lázaro I; Cofán M; Jarauta E; Plana N; Garcia-Otín AL; Ascaso JF; Ferré R; Civeira F; Ros E; Masana L
J Lipid Res; 2010 May; 51(5):1173-8. PubMed ID: 20388924
[TBL] [Abstract][Full Text] [Related]
67. Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias.
Naukkarinen J; Nilsson E; Koistinen HA; Söderlund S; Lyssenko V; Vaag A; Poulsen P; Groop L; Taskinen MR; Peltonen L
Circ Cardiovasc Genet; 2009 Oct; 2(5):522-9. PubMed ID: 20031629
[TBL] [Abstract][Full Text] [Related]
68. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.
Meijssen S; Cabezas MC; Twickler TB; Jansen H; Erkelens DW
J Lipid Res; 2000 Jul; 41(7):1096-102. PubMed ID: 10884291
[TBL] [Abstract][Full Text] [Related]
69. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.
Morello F; de Bruin TW; Rotter JI; Pratt RE; van der Kallen CJ; Hladik GA; Dzau VJ; Liew CC; Chen YD
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2149-54. PubMed ID: 15388524
[TBL] [Abstract][Full Text] [Related]
70. Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Geurts JM; Flavell DM; de Bruin TW
Mol Genet Metab; 2002 Dec; 77(4):274-81. PubMed ID: 12468272
[TBL] [Abstract][Full Text] [Related]
71. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
72. USF1 deficiency activates brown adipose tissue and improves cardiometabolic health.
Laurila PP; Soronen J; Kooijman S; Forsström S; Boon MR; Surakka I; Kaiharju E; Coomans CP; Van Den Berg SA; Autio A; Sarin AP; Kettunen J; Tikkanen E; Manninen T; Metso J; Silvennoinen R; Merikanto K; Ruuth M; Perttilä J; Mäkelä A; Isomi A; Tuomainen AM; Tikka A; Ramadan UA; Seppälä I; Lehtimäki T; Eriksson J; Havulinna A; Jula A; Karhunen PJ; Salomaa V; Perola M; Ehnholm C; Lee-Rueckert M; Van Eck M; Roivainen A; Taskinen MR; Peltonen L; Mervaala E; Jalanko A; Hohtola E; Olkkonen VM; Ripatti S; Kovanen PT; Rensen PC; Suomalainen A; Jauhiainen M
Sci Transl Med; 2016 Jan; 8(323):323ra13. PubMed ID: 26819196
[TBL] [Abstract][Full Text] [Related]
73. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen MR; Peltonen L; Ehnholm C
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1810-7. PubMed ID: 9812922
[TBL] [Abstract][Full Text] [Related]
74. A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia.
Huertas-Vazquez A; Plaisier CL; Geng R; Haas BE; Lee J; Greevenbroek MM; van der Kallen C; de Bruin TW; Taskinen MR; Alagramam KN; Pajukanta P
Hum Genet; 2010 Jan; 127(1):83-9. PubMed ID: 19816713
[TBL] [Abstract][Full Text] [Related]
75. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
Cortner JA; Coates PM; Liacouras CA; Jarvik GP
J Pediatr; 1993 Aug; 123(2):177-84. PubMed ID: 8345411
[TBL] [Abstract][Full Text] [Related]
76. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
Austin MA; Brunzell JD; Fitch WL; Krauss RM
Arteriosclerosis; 1990; 10(4):520-30. PubMed ID: 2369363
[TBL] [Abstract][Full Text] [Related]
77. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.
Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Perez-Calahorra S; Bea AM; Marco-Benedí V; Jarauta E; Mateo-Gallego R; Civeira F
J Nutr Biochem; 2018 Mar; 53():48-57. PubMed ID: 29190549
[TBL] [Abstract][Full Text] [Related]
78. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.
Kuromori Y; Okada T; Iwata F; Hara M; Noto N; Harada K
J Atheroscler Thromb; 2002; 9(6):314-20. PubMed ID: 12560593
[TBL] [Abstract][Full Text] [Related]
79. The rs2516839 Polymorphism of the USF1 Gene May Modulate Serum Triglyceride Levels in Response to Cigarette Smoking.
Niemiec P; Nowak T; Iwanicki T; Gorczynska-Kosiorz S; Balcerzyk A; Krauze J; Grzeszczak W; Wiecha M; Zak I
Int J Mol Sci; 2015 Jun; 16(6):13203-16. PubMed ID: 26068452
[TBL] [Abstract][Full Text] [Related]
80. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR
Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
